Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Retained Earnings (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Retained Earnings readings, the most recent being -$6.2 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 9.09% to -$6.2 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$6.2 million, a 9.09% decrease, with the full-year FY2025 number at -$5.9 million, down 10.29% from a year prior.
  • Retained Earnings reached -$6.2 million in Q1 2026 per CBIH's latest filing, down from -$6.1 million in the prior quarter.
  • The five-year high for Retained Earnings was -$4.7 million in Q2 2023, with the low at -$6.2 million in Q1 2026.
  • A 4-year average of -$5.6 million and a median of -$5.5 million in 2024 define the central range for Retained Earnings.
  • Peak annual rise in Retained Earnings hit 5.61% in 2024, while the deepest fall reached 13.91% in 2024.
  • Year by year, Retained Earnings stood at -$5.2 million in 2023, then decreased by 5.61% to -$5.5 million in 2024, then decreased by 10.79% to -$6.1 million in 2025, then dropped by 1.71% to -$6.2 million in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Retained Earnings are -$6.2 million (Q1 2026), -$6.1 million (Q4 2025), and -$6.0 million (Q3 2025).